Bioporto Q4 Adj EBITDA Loss Down At 17.9 Mln

March 30, 2023 06:09 PM AEDT | By Reuters
Follow us on Google News:

March 30 (Reuters) - Bioporto A/S:

* BIOPORTO ANNOUNCES ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022

* Q4 ADJUSTED EBITDA LOSS OF DKK 17.9 MILLION

* BECAUSE OF GROUP’S NEED FOR CAPITAL TO IMPLEMENT ITS STRATEGIC INITIATIVES, ACHIEVE HIGHER SALES, NO DIVIDEND IS EXPECTED TO BE PAID IN 2023

* OUTLOOK 2023: ADJUSTED EBITDA LOSS ABOUT DKK (60) TO (65) MILLION

* OUTLOOK 2023: REVENUE AT ABOUT DKK 30 TO 33 MILLION

* PERFORMANCE AND GUIDANCE FOR 2023 ARE DEPENDENT ON CONTINUED RESOLUTION OF COVID-19 PANDEMIC Source text for Eikon: Further company coverage: (Gdansk Newsroom)


Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK